Page last updated: 2024-10-23

bevantolol and Myocardial Ischemia

bevantolol has been researched along with Myocardial Ischemia in 1 studies

bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toleikis, PM1
Tomlinson, CW1

Other Studies

1 other study available for bevantolol and Myocardial Ischemia

ArticleYear
Myocardial functional preservation during ischemia: influence of beta blocking agents.
    Molecular and cellular biochemistry, 1997, Volume: 176, Issue:1-2

    Topics: Adrenergic beta-Antagonists; Animals; Heart; Heart Function Tests; Male; Myocardial Infarction; Myoc

1997